• 1
    Bestard O, Cruzado JM, Franquesa M, Grinyó JM. Biomarkers in renal transplantation. Curr Opin Organ Transplant 2010; 15: 467473. Review.
  • 2
    Sawitzki B, Schlickeiser S, Reinke P, Volk HD. Monitoring tolerance and rejection in organ transplant recipients. Biomarkers 2011; 16 (Suppl 1): S42S50. Review.
  • 3
    Roelen DL, Doxiadis II, Claas FH. Detection and clinical relevance of donor specific HLA antibodies: A matter of debate. Transpl Int 2012; 25: 604610.
  • 4
    Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? Transplantation 2008; 85: 1200.
  • 5
    van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086.
  • 6
    Billen EV, Christiaans MH, van denBerg-Loonen EM. Clinical relevance of Luminex donor-specific crossmatches: Data from 165 renal transplants. Tissue Antigens 2009; 74: 205.
  • 7
    Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008; 8: 2335.
  • 8
    Heeger PS. T-cell allorecognition and transplant rejection: A summary and update. Am J Transplant 2003; 3: 5255233. Review.
  • 9
    Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol 2010; 6: 155169. Review.
  • 10
    Valujskikh A. Memory T cells in allograft rejection. Adv Exp Med Biol 2007; 601: 247256. Review.
  • 11
    Nickel P, Presber F, Bold G, et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 2004; 78: 16401646.
  • 12
    Bestard O, Nickel P, Cruzado JM, et al. Circulating alloreactive T cells correlate with graft function in longstanding renal transplant recipients. J Am Soc Nephrol 2008; 19: 14191429.
  • 13
    Augustine JJ, Poggio ED, Clemente M, et al. Hemodialysis vintage, black ethnicity, and pretransplantation antidonor cellular immunity in kidney transplant recipients. J Am Soc Nephrol 2007; 18: 16021606.
  • 14
    Poggio ED, Augustine JJ, Clemente M, et al. Pretransplant cellular alloimmunity as assessed by a panel of reactive T cells assay correlates with acute renal graft rejection. Transplantation 2007; 83: 847852.
  • 15
    Andree H, Nickel P, Nasiadko C, et al. Identification of dialysis patients with panel-reactive memory T cells before kidney transplantation using an allogeneic cell bank. J Am Soc Nephrol 2006; 17: 573580.
  • 16
    Amir AL, D'Orsogna LJ, Roelen DL, et al. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 2010; 115: 31463157.
  • 17
    Segall M, Noreen H, Edwins L, Haake R, Shu XO, Kersey J. Lack of correlation of MLC reactivity with acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation. Hum Immunol 1996; 49: 4955.
  • 18
    Hernandez-Fuentes MP, Warrens AN, Lechler RI. Immunologic monitoring. Immunol Rev 2003; 196: 247264.
  • 19
    van Besouw NM, Zuijderwijk JM, de Kuiper P, Ijzermans JN, Weimar W, van der Mast BJ. The granzyme B and interferon-gamma enzyme-linked immunospot assay as alternatives for cytotoxic T-lymphocyte precursor frequency after renal transplantation. Transplantation 2005; 79: 10621066.
  • 20
    Hernandez-Fuentes MP, Salama A. In vitro assays for immune monitoring in transplantation. Methods Mol Biol 2006; 333: 269290.
  • 21
    Kreijveld E, Koenen HJ, van Cranenbroek B, van Rijssen E, Joosten I, Hilbrands LB. Immunological monitoring of renal transplant recipients to predict acute allograft rejection following the discontinuation of tacrolimus. PLoS ONE 2008; 3: e2711.
  • 22
    van der Mast BJ, Rischen-Vos J, de Kuiper P, Vaessen LM, van Besouw NM, Weimar W. Calcineurin inhibitor withdrawal in stable kidney transplant patients decreases the donor-specific cytotoxic T lymphocyte precursor frequency. Transplantation 2005; 80: 12201225.
  • 23
    Steinmann J, Kaden J, May G, Schroder K, Herwartz C, Muller-Ruchholtz W. Failure of in vitro T-cell assays to predict clinical outcome after human kidney transplantation. J Clin Lab Anal 1994; 8: 157162.
  • 24
    Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 22672275.
  • 25
    Gebauer BS, Hricik DE, Atallah A, et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857866.
  • 26
    Nather BJ, Nickel P, Bold G, et al. Modified ELISPOT technique—Highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients. Transpl Immunol 2006; 16: 232237.
  • 27
    Janetzki S, Panageas KS, Ben-Porat L, et al. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI). Cancer Immunol Immunother 2008; 57: 303315.
  • 28
    Zhang W, Caspell R, Karulin AY et al. ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring–even in hands of ELISPOT- inexperienced investigators. J Immunotoxicol 2009; 6: 227234.